47218-35-9Relevant academic research and scientific papers
A chloroquinoline derivate presents effective in vitro and in vivo antileishmanial activity against Leishmania species that cause tegumentary and visceral leishmaniasis
Sousa, Jessica K.T.,Antinarelli, Luciana M.R.,Mendon?a, Débora V.C.,Lage, Daniela P.,Tavares, Grasiele S.V.,Dias, Daniel S.,Ribeiro, Patrícia A.F.,Ludolf, Fernanda,Coelho, Vinicio T.S.,Oliveira-da-Silva, Jo?o A.,Perin, Luísa,Oliveira, Bianka A.,Alvarenga, Denis F.,Chávez-Fumagalli, Miguel A.,Brand?o, Geraldo C.,Nobre, Vandack,Pereira, Guilherme R.,Coimbra, Elaine S.,Coelho, Eduardo A.F.
, (2019)
The identification of new therapeutics to treat leishmaniasis is desirable, since available drugs are toxic and present high cost and/or poor availability. Therefore, the discovery of safer, more effective and selective pharmaceutical options is of utmost
